Recent patient data surrounding the medication Retatrutide , specifically the high-dose formulation branded as ZPHC, suggest a impressive effect on physique reduction and related chronic conditions . Researchers posit that this dual acting , targeting both GLP-1 and GIP receptors , may represent a noteworthy breakthrough more info in the management